Abstract:When testing association between rare variants and diseases, an efficient analytical approach involves considering a set of variants in a genomic region as the unit of analysis. One factor complicating this approach is that the vast majority of rare variants in practical applications are believed to represent background neutral variation. As a result, analyzing a single set with all variants may not represent a powerful approach. Here, we propose two alternative strategies. In the first, we analyze the subsets of rare variants exhaustively. In the second, we categorize variants selectively into two subsets: one in which variants are overrepresented in cases, and the other in which variants are overrepresented in controls. When the proportion of neutral variants is moderate to large we show, by simulations, that the both proposed strategies improve the statistical power over methods analyzing a single set with total variants. When applied to a real sequencing association study, the proposed methods consistently produce smaller p-values than their competitors. When applied to another real sequencing dataset to study the difference of rare allele distributions between ethnic populations, the proposed methods detect the overrepresentation of variants between the CHB (Chinese Han in Beijing) and YRI (Yoruba people of Ibadan) populations with small p-values. Additional analyses suggest that there is no difference between the CHB and CHD (Chinese Han in Denver) datasets, as expected. Finally, when applied to the CHB and JPT (Japanese people in Tokyo) populations, existing methods fail to detect any difference, while it is detected by the proposed methods in several regions.

Searching PubMed for articles relevant to clinical interpretation of rare human genetic variants

Major Causes of Conflicting Interpretations of Variant Pathogenicity in Rare Disease: A Systematic Analysis

ClinVar: improving access to variant interpretations and supporting evidence

Toward Automatic Variant Interpretation: Discordant Genetic Interpretation Across Variant Annotations for ClinVar Pathogenic Variants

Reasons and Resolutions for Inconsistent Variant Interpretation

Understanding genetic variants in context

Capturing All Disease-Causing Mutations for Clinical and Research Use: Toward an Effortless System for the Human Variome Project

Missing genetic diversity impacts variant prioritisation for rare disorders

The functional genomics laboratory: functional validation of genetic variants

Bioinformatic Challenges Detecting Genetic Variation in Precision Medicine Programs

Evaluation of an Automated Genome Interpretation Model for Rare Disease Routinely Used in a Clinical Genetic Laboratory.

Rare and low-frequency variants in human common diseases and other complex traits

Evaluation of an Automated Genome Interpretation Model for Rare Disease Routinely Used in a Clinical Genetic Lab

Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project

LitGen: Genetic Literature Recommendation Guided by Human Explanations

Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges

Comparison of Literature Mining Tools for Variant Classification: Through the Lens of Fifty RYR1 Variants

Efficient Utilization of Rare Variants for Detection of Disease-Related Genomic Regions

A comparative medical genomics approach may facilitate the interpretation of rare missense variation

Characterizing the Genetic Polymorphisms in 370 Challenging Medically Relevant Genes Using Long-Read Sequencing Data from 41 Human Individuals among 19 Global Populations

Utilizing ClinGen gene‐disease validity and dosage sensitivity curations to inform variant classification